Bimatoprost is a synthetic prostamide analogue that lowers intraocular pressure in glaucoma by enhancing aqueous humour outflow, and is separately used cosmetically to promote eyelash growth. Simson Pharma's Bimatoprost reference standard and impurities support compendial testing across both ophthalmic and cosmetic formulations.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bimatoprost Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.